PPD and Merck in Strategic Outsourcing Deal

Tuesday, January 6, 2009 11:25 AM

Contract research organization (CRO) PPD has entered into a strategic collaboration with Merck that will significantly expand PPD’s global central laboratory business.

Under the terms of the agreement, PPD assumes control of Merck’s 130,000-square-foot vaccine testing laboratory and related equipment in Wayne, Pa., as well as 80 Merck employees who operate the facility.

PPD will provide a range of assay development and immunogenicity testing services as well as traditional central laboratory and sample storage services to Merck over the next five years.

“With this acquisition, we believe we are the first CRO to have a central lab that offers a comprehensive menu of assay development and testing services for vaccine clinical trials,” said Agostino Fede, senior vice president of PPD and head of global central labs, in a company release.

The PPD-Merck agreement is just the latest example of the growing trend toward strategic outsourcing agreements between CROs and big pharma. In August, Covance and Eli Lilly signed a $1.6-billion agreement to sell a major R&D facility to Covance. Lilly also cut smaller outsourcing agreements with Quintiles and i3 Statprobe in 2008.

PPD did not disclose financial details of the transaction. PPD’s shares were down 2.04% to $28.40 at end of day Monday.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs